Krystal Biotech Ratios (2016-2026) | KRYS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)										97.39%	93.19%	94.66%	91.45%	92.03%	94.57%	94.30%	92.54%	95.64%	93.85%	94.57%
EBT Margin (Quarter)										943.75%	25.29%	2.06%	22.82%	35.51%	53.35%	49.44%	48.72%	49.05%	47.74%	52.80%
EBIT Margin (Quarter)										-303.80%	7.71%	-14.75%	12.18%	26.80%	45.41%	41.11%	40.94%	42.30%	41.34%	46.14%
EBITDA Margin (Quarter)										942.04%	23.05%	-0.01%	21.67%	34.98%	48.05%	41.18%	40.73%	81.09%	48.03%	45.70%
Operating Margin (Quarter)										-303.80%	7.71%	-14.75%	12.18%	26.80%	45.41%	41.11%	40.94%	42.30%	41.34%	46.14%
Net Margin (Quarter)										943.75%	20.63%	2.06%	22.15%	32.42%	49.95%	40.52%	39.97%	81.15%	47.99%	48.07%
FCF Margin (Quarter)										-249.31%	-11.23%	16.41%	2.70%	68.95%	57.12%	33.53%	47.94%	48.20%	70.09%	62.94%
Efficiency
Inventory Average (Quarter)											6.13M	9.01M	11.61M	15.38M	22.54M	28.23M	30.49M	34.34M	39.05M	41.56M
Assets Average (Quarter)	443.29M	447.33M	538.70M	621.58M	609.10M	588.85M	567.41M	545.15M	607.94M	737.19M	804.35M	835.83M	885.48M	949.99M	1,019.08M	1,065.13M	1,106.40M	1,189.24M	1,286.94M	1,365.38M
Equity Average (Quarter)	424.60M	413.39M	500.91M	571.07M	553.87M	549.98M	531.50M	505.90M	571.34M	704.53M	767.29M	788.94M	819.07M	862.37M	916.11M	965.53M	1,012.66M	1,089.26M	1,178.72M	1,248.14M
Invested Capital (Quarter)	418.54M	408.24M	593.58M	548.55M	559.18M	540.77M	522.23M	489.57M	653.11M	755.95M	778.64M	799.24M	838.89M	885.85M	946.38M	984.67M	1,040.65M	1,137.88M	1,219.56M	1,276.73M
Asset Utilization Ratio (Quarter)										0.01	0.06	0.11	0.19	0.25	0.29	0.31	0.32	0.31	0.30	0.31
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.94	0.90	0.95	0.89	0.93	0.94	0.94	0.92	0.95	0.96	0.95	0.94	0.91	0.90	0.90	0.92	0.91	0.92	0.91	0.91
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-367.73M	-343.09M	-438.10M	-434.63M	-425.56M	-394.42M	-379.17M	-350.39M	-477.52M	-562.07M	-532.18M	-538.26M	-559.61M	-588.32M	-597.52M	-616.85M	-681.99M	-731.07M	-827.79M	-823.40M
Return Ratios
Return on Sales (Quarter)										0.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%
Return on Capital Employed (Quarter)	-11.96%	-13.81%	-13.31%	-18.56%	-20.27%	-23.59%	-26.96%	-28.19%	-26.21%	-20.81%	-14.21%	-8.56%	-2.56%	3.21%	7.17%	11.02%	13.67%	14.42%	13.62%	14.21%
Return on Invested Capital (Quarter)												0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Krystal Biotech Ratios (2016-2026) | KRYS

Research Tools

Developers

Krystal Biotech Ratios (2016-2026) | KRYS

Create an account

Sign In

Reset Password